Your browser doesn't support javascript.
loading
B-cell repopulation dynamics and drug pharmacokinetics impact SARS-CoV-2 vaccine efficacy in anti-CD20-treated multiple sclerosis patients.
Asplund Högelin, Klara; Ruffin, Nicolas; Pin, Elisa; Hober, Sophia; Nilsson, Peter; Starvaggi Cucuzza, Chiara; Khademi, Mohsen; Olsson, Tomas; Piehl, Fredrik; Al Nimer, Faiez.
Afiliação
  • Asplund Högelin K; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Ruffin N; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Pin E; SciLifeLab, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Hober S; SciLifeLab, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Nilsson P; SciLifeLab, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Starvaggi Cucuzza C; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Khademi M; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Olsson T; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Piehl F; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Al Nimer F; Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Eur J Neurol ; 29(11): 3317-3328, 2022 Nov.
Article em En | MEDLINE | ID: mdl-35808856
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Vacinas contra COVID-19 / COVID-19 / Esclerose Múltipla Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Vacinas contra COVID-19 / COVID-19 / Esclerose Múltipla Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia